Fluidigm (FLDM -32.6%) slumps on increased volume in early trade after the company posted less-than-expected Q2 results after the close yesterday.
Revenue was up 7% to $28.2M, mass cytometry revenue was up 28% to $17.5M.
Net loss: ($13.8M) (+15%); EPS: ($0.20) (+52%).
Q3 guidance: Revenue: $27M – 30M; cash consumption: $7M – 9M.
Previously: Fluidigm EPS misses by $0.03, misses on revenue (Aug. 1)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.